External validation of P2/MS and comparison with other simple non-invasive indices for predicting liver fibrosis in HBV-infected patients

Digestive Diseases and Sciences

Volumn 55, Issue 9, 2010, Pages 2636-2643

  Kim, Beom Kyung ^a   Han, Kwang Hyub ^a,b,c,d   Park, Jun Yong ^a,b,c   Ahn, Sang Hoon ^a,b,c   Chon, Chae Yoon ^a,b,c   Kim, Ja Kyung ^a,b,c   Paik, Yong Han ^a,b,c,d   Lee, Kwan Sik ^a,b,c   Park, Young Nyun ^a   Kim, Do Young ^a,b,c  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Liver Cirrhosis Clinical Research Center   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

Chronic hepatitis B; Cirrhosis; Liver biopsy; P2 MS; Prediction; Validation

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; DIAGNOSTIC TEST; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; P2/MS TEST; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; VALIDATION PROCESS;

ADULT; AGE FACTORS; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOPSY, NEEDLE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS INDICATORS; HEPATITIS B; HUMANS; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MONOCYTES; NEUTROPHILS; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 77956183604     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1070-3     Document Type: Article

References (34)

1. AS Lok BJ Mcmahon 2007 Chronic hepatitis B Hepatology 45 507 539 10.1002/hep.21513 1:CAS:528:DC%2BD2sXisVKns7o%3D 17256718 (Pubitemid 46374607)
2. R De Franchis 2008 Non-invasive (and minimally invasive) diagnosis of oesophageal varices J Hepatol 49 520 527 10.1016/j.jhep.2008.07.009 18706733
3. G Spinzi V Terruzzi G Minoli 2001 Liver biopsy N Engl J Med 344 2030 1:STN:280:DC%2BD3MzntlGrug%3D%3D 11430340
4. T Poynard P Halfon L Castera, et al. 2007 Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation Aliment Pharmacol Ther 25 733 739 10.1111/j.1365-2036.2007.03252.x 1:STN:280: DC%2BD2s7pt1Sqsg%3D%3D 17311607
5. CT Wai JK Greenson RJ Fontana, et al. 2003 A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 518 526 10.1053/jhep.2003.50346 12883497 (Pubitemid 36919874)
6. X Forns SS Ampurdan JM Llovet, et al. 2002 Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 986 992 12297848
7. F Imbert-Bismut V Ratziu L Pieroni, et al. 2001 Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Lancet 357 1069 1075 10.1016/S0140-6736(00)04258-6 1:CAS:528: DC%2BD3MXislGns70%3D 11297957 (Pubitemid 32322537)
8. KH Han KT Yoon 2008 New diagnostic method for liver fibrosis and cirrhosis Intervirology 51 1 11 16 10.1159/000122594 18544943 (Pubitemid 351821837)
9. C Lackner G Struber B Liegl, et al. 2005 Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C Hepatology 41 1376 1382 10.1002/hep.20717 15915455 (Pubitemid 40770291)
10. C Wai CL Cheng A Wee, et al. 2006 Non-invasive models for predicting histology in patients with chronic hepatitis B Liver Int 26 666 672 10.1111/j.1478-3231.2006.01287.x 16842322 (Pubitemid 43983883)
11. L Cast Ra J Vergniol J Foucher, et al. 2005 Prospective comparison of transient elastography, FibroTest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 343 350 10.1053/j.gastro.2004.11.018 (Pubitemid 40439195)
12. M Friedrich-Rust MF Ong S Martens, et al. 2008 Performance of transient elastography for the staging of liver fibrosis: a meta-analysis Gastroenterology 134 960 974 10.1053/j.gastro.2008.01.034 18395077 (Pubitemid 351451980)
13. M Ziol A Handra-Luca A Kettaneh, et al. 2005 Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C Hepatology 41 48 54 10.1002/hep.20506 15690481 (Pubitemid 40066382)
14. A Vallet-Pichard V Mallet B Nalpas, et al. 2007 FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest Hepatology 46 32 36 10.1002/hep.21669 1:CAS:528:DC%2BD2sXosVyltrg%3D 17567829 (Pubitemid 47171918)
15. SP Cal F Oberti S Michalak, et al. 2005 A novel panel of blood markers to assess the degree of liver fibrosis Hepatology 42 1373 1381 10.1002/hep.20935 (Pubitemid 43260040)
16. JH Lee JH Yoon CH Lee, et al. 2009 Complete blood count reflects the degree of oesophageal varices and liver fibrosis in virus-related chronic liver disease patients J Viral Hepat 16 444 452 10.1111/j.1365-2893.2009.01091.x 19200133
17. SG Sheth SL Flamm FD Gordon, et al. 1998 AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection Am J Gastroenterol 93 44 48 10.1111/j.1572-0241.1998.044-c.x 1:STN:280:DyaK1c7gslylsw%3D%3D 9448172 (Pubitemid 29065511)
18. T Poynard P Bedossa 1997 Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups J Viral Hepat 4 199 208 10.1046/j.1365-2893.1997.00141.x 1:STN:280:DyaK2szisFCktA%3D%3D 9181529
19. BK Kim SA Kim YN Park, et al. 2007 Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B Liver Int 27 969 976 10.1111/j.1478-3231.2007.01519.x 1:CAS:528:DC%2BD2sXhtFKntrbM 17696936 (Pubitemid 47261951)
20. A Vallet-Pichard V Mallet S Pol 2006 FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients Hepatology 44 769 770 10.1002/hep.21334 16941681 (Pubitemid 44433734)
21. P Bedossa T Poynard 1996 An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 289 293 10.1002/hep.510240201 1:STN:280:DyaK28zhvFClug%3D%3D 8690394
22. JA Hanley BJ Mcneil 1983 A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 148 839 843 1:STN:280:DyaL3s3nsVKgtg%3D%3D 6878708
23. RK Sterling E Lissen N Clumeck, et al. 2006 Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection Hepatology 43 1317 1325 10.1002/hep.21178 1:CAS:528: DC%2BD28XmsF2nur0%3D 16729309 (Pubitemid 43980111)
24. SD Taylor-Robinson RD Goldin JV Hajnal, et al. 2003 The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C Hepatology 37 788 794 10.1053/jhep.2003.50149 12668971 (Pubitemid 36397389)
25. D Chen J Kao J Chen, et al. 2007 Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index Clin Gastroenterol Hepatol 5 1199 1206.e1 10.1016/j.cgh.2007.07.016 17916547 (Pubitemid 47488971)
26. RL Ehman JL Fidler PJ Rossman, et al. 2007 Assessment of hepatic fibrosis with magnetic resonance elastography Clin Gastroenterol Hepatol 5 1207 1213.e2 10.1016/j.cgh.2007.06.012 17916548 (Pubitemid 47488968)
27. PE Chang HF Lui YP Chau, et al. 2008 Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index Aliment Pharmacol Ther 28 51 61 10.1111/j.1365-2036.2008.03711.x 1:CAS:528:DC%2BD1cXovFelsbk%3D 18410556 (Pubitemid 351782817)
28. NH Afdhal D Nunes 2004 Evaluation of liver fibrosis: a concise review Am J Gastroenterol 99 1160 1174 10.1111/j.1572-0241.2004.30110.x 15180741 (Pubitemid 38917824)
29. EG Giannini 2006 Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options Aliment Pharmacol Ther 23 1055 1065 10.1111/j.1365-2036.2006.02889.x 1:CAS:528:DC%2BD28Xlt1aktLc%3D 16611265 (Pubitemid 43779344)
30. G Cioni E Tincani P D'Alimonte, et al. 1993 Relevance of reduced portal flow velocity, low platelet count and enlarged spleen diameter in the non-invasive diagnosis of compensated liver cirrhosis Eur J Med 2 408 410 1:STN:280:DyaK2c%2FotVCisA%3D%3D 8258029
31. AW Wognum Y Westerman TP Visser, et al. 1994 Distribution of receptors for granulocyte-macrophage colony-stimulating factor on immature CD34 + bone marrow cells, differentiating monomyeloid progenitors, and mature blood cell subsets Blood 84 764 774 1:CAS:528:DyaK2cXlsV2ltb8%3D 7519073
32. A Kubota S Okamura F Omori, et al. 1995 High serum levels of granulocyte-macrophage colony-stimulating factor in patients with liver cirrhosis and granulocytopenia Clin Lab Haematol 17 61 63 10.1111/j.1365-2257. 1995.tb00319.x 1:STN:280:DyaK2MzkslWhtA%3D%3D 7621631
33. EH Blackstone 2001 Breaking down barriers: helpful breakthrough statistical methods you need to understand better J Thorac Cardiovasc Surg 122 430 439 10.1067/mtc.2001.117536 1:STN:280:DC%2BD3MvpvVansQ%3D%3D 11547291 (Pubitemid 32843940)
34. GL Grunkemeier Y Wu 2004 Bootstrap resampling methods: something for nothing? Ann Thorac Surg 77 1142 1144 10.1016/j.athoracsur.2004.01.005 15063219 (Pubitemid 38452333)